The Arab Drug Company (CASE: ADCI)
Health Care · Pharmaceuticals · EG
EGP286.96
-7.38% today · +96.3% 1Y
The Arab Drug Company (CASE: ADCI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $67.68M.
Over the last twelve months the share price has gained 96.3%, trading between 132.00 and 389.99.
Tweenvest scores The Arab Drug Company across four factors: quality 72/100, value 28/100, growth 47/100, dividend 33/100. Its strongest factor is quality.
ADCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $67.68M
- Revenue (TTM)
- $24.29M
- P/E
- 15.03
- EPS
- 19.09
- Dividend yield
- 1.45%
- Beta (5Y)
- 0.54
- 52-week high
- EGP389.99
- 52-week low
- EGP132.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.